Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Accumulated Expenses (2023 - 2025)

Upstream Bio (UPB) has 3 years of Accumulated Expenses data on record, last reported at $3.0 million in Q3 2025.

  • For Q3 2025, Accumulated Expenses rose 51.93% year-over-year to $3.0 million; the TTM value through Sep 2025 reached $3.0 million, up 51.93%, while the annual FY2024 figure was $2.7 million, 39.8% down from the prior year.
  • Accumulated Expenses reached $3.0 million in Q3 2025 per UPB's latest filing, down from $7.7 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $7.7 million in Q2 2025 and bottomed at $2.0 million in Q3 2024.
  • Average Accumulated Expenses over 3 years is $4.0 million, with a median of $3.6 million recorded in 2025.
  • Peak YoY movement for Accumulated Expenses: plummeted 39.8% in 2024, then skyrocketed 51.93% in 2025.
  • A 3-year view of Accumulated Expenses shows it stood at $4.5 million in 2023, then crashed by 39.8% to $2.7 million in 2024, then rose by 12.61% to $3.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $3.0 million in Q3 2025, $7.7 million in Q2 2025, and $4.1 million in Q1 2025.